RxNorm Names
RESCON MX
(dexchlorpheniramine maleate)
tablet
[Capellon Pharmaceuticals, LLC]
Permanent Link:
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e9a1b25-6fb4-4790-af1c-77a995f2f8c8| Category | DEA Schedule | Marketing Status |
|---|---|---|
| HUMAN OTC DRUG LABEL | OTC monograph final |
NOTE:MOST OTC DRUGS ARE NOT REVIEWED AND APPROVED BY FDA, HOWEVER THEY MAY BE MARKETED IF THEY COMPLY WITH APPLICABLE REGULATIONS AND POLICIES. FDA HAS NOT EVALUATED WHETHER THIS PRODUCT COMPLIES.
Uses
Temporarily relieves these symptoms due to hay fever (allergic rhinitis):
- runny nose
- sneezing
- itchy, watery eyes
- itching of the nose or throat
Ask a doctor before use if you have
- glaucoma
- trouble urinating due to an enlarged prostate gland
- a breathing problem such as emphysema or chronic bronchitis
- are taking sedatives or tranquilizers
When using this product
- drowsiness may occur
- avoid alcoholic beverages
- alcohol, sedatives, and tranquilizers may increase drowsiness
- be careful when driving a motor vehicle or operating machinery
Keep out of reach of children
In case of accidental overdose, seek professional assistance or contact a Poison Control Center immediately.
Directions
Do not exceed 6 doses in a 24-hour period
| Age | Dose |
| Adults and children over 12 years of age | 1 tablet every 4 to 6 hours |
| Children under 12 years of age | Consult with a physician |
Inactive Ingredients
colloidal silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch, and stearic acid.
| RESCON MX
dexchlorpheniramine maleate tablet |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
| Labeler - Capellon Pharmaceuticals, LLC (124568093) |
| Registrant - Capellon Pharmaceuticals, LLC (124568093) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
| Sovereign Pharmaceuticals, LLC | 623168267 | MANUFACTURE(64543-092) | |
Revised: 08/2011
Document Id: dcc88ac4-c397-4610-abf8-854072540e66
Set id: 3e9a1b25-6fb4-4790-af1c-77a995f2f8c8
Version: 1
Effective Time: 20110805
Capellon Pharmaceuticals, LLC
Review RxNorm Normal Forms